share_log

国药控股(01099.HK)遭摩根大通减持133.77万股

Sinopharm (01099.HK) faces shareholding of 1.3377 million shares by JPMorgan.

Gelonghui Finance ·  18:31

On July 19th, 2024, Sinopharm (01099.HK) suffered a shareholding reduction of 1.3377 million shares from JPMorgan Chase & Co. at an average price of HKD 18.8408 per share, involving approximately HKD 25.2025 million, according to the latest equity disclosure data from the Hong Kong Stock Exchange.

After the reduction, JPMorgan Chase & Co.'s latest number of shares held is 93.9033 million shares, and the shareholding ratio has decreased from 7.09% to 6.99%.

big
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment